ERO1L Promotes Hepatic Metastasis through Activating Epithelial-Mesenchymal Transition (EMT) in Pancreatic Cancer

Figure 3

Pharmacological inhibition of ERO1L suppresses migration and invasion of PDAC in vitro. (a) Transwell assays with/without coated Matrigel showing the role of ERO1L inhibitor, EN460 in PDAC cell migration in vitro. (b) Transwell assays with/without coated Matrigel showing the role of ERO1L inhibitor, EN460 in PDAC cell invasion in vitro.

(a)

(b)